Wockhardt and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) have partnered to produce and supply Sputnik V and Sputnik Light vaccines against COVID-19. The agreement was reached under the aegis of Enso Healthcare (part of Enso Group), RDIF's coordination partner for sourcing Sputnik V vaccines in India.
Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.